BIOL — BIOLASE Cashflow Statement
0.000.00%
Last trade - 00:00- $4.52m
- $14.20m
- $49.16m
- 23
- 60
- 11
- 22
Annual cashflow statement for BIOLASE, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.9 | -16.8 | -16.2 | -28.6 | -20.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.23 | 1.78 | 0.985 | 6.45 | 2.72 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.11 | 1.75 | -1.94 | -5.07 | 1.02 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -12.7 | -12.8 | -16.7 | -26.8 | -14.1 |
| Capital Expenditures | -0.207 | -0.096 | -0.707 | -3.73 | -1.31 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | 0.182 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.207 | -0.096 | -0.707 | -3.73 | -1.13 |
| Financing Cash Flow Items | -0.954 | -3.05 | -1.14 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.7 | 24.3 | 30 | 4.6 | 17.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.25 | 11.8 | 12.3 | -26 | 2.38 |